A specific vascular endothelial growth factor receptor tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in human epidermal growth factor receptor 2 overexpressing breast cancer cell lines
Kim, Elizabeth M.H., M.D, Lobocki, Catherine, M.S, Dubay, Linda, M.D, Mittal, Vijay K., M.D
Published in The American journal of surgery (01.03.2009)
Published in The American journal of surgery (01.03.2009)
Get full text
Journal Article